While the Prrx-1 inducible model replicates key features of human FD,8,29 there are subtle but relevant differences, including a higher baseline proportion of bone content within fibro-osseous lesions and the inability to use this transgenic model to investigate the effects of RANKL inhibition on the regulation of FD Gαs expression. Here, PRRX1 is linked to Fabry disease.